Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00215332 · ClinicalTrials.gov registry record

CHARITE™ vs. ALIF 5-Year Follow-up

A clinical trial of Degenerative Disc Disease, sponsored by DePuy Spine.

Completed
Registry status
367
Enrollment target
10
Study locations

NCT00215332 is a study of Degenerative Disc Disease that has completed, run by DePuy Spine. The registered enrollment target is 367 participants, above the 160-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (129% higher). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00215332, a study of Degenerative Disc Disease, has completed, sponsored by DePuy Spine.

COMPLETED
Registry status
367 participants
Enrollment target
10
Study locations

Study Summary

To assess the clinical and radiographic outcomes through 5-years following treatment with CHARITÉ™ Artificial Disc vs. the BAK Cage for treatment of degenerative disc disease at one level (L4-S1).

Conditions Studied

Interventions

  • DEVICE CHARITE

Study Locations (10)

New York

  • Charite Site 14 - Lockport
  • Charite Site 10 - New York

California

  • Charite Site 13 - Los Angeles

Colorado

  • Charite Site 06 - Golden

Illinois

  • Charite Site 11 - Chicago

Kentucky

  • Charite Site 03 - Louisville

Maryland

  • Charite Site 02 - Towson

Massachusetts

  • Charite Site 15 - Boston

Ohio

  • Charite Site 07 - Columbus

Trial Details

FieldValue
Enrollment Target 367 participants
Start Date 2005-03
Est. Completion 2007-07

Sponsor

DePuy Spine

5 total trials

What the Registry Record Tells You About NCT00215332

The ClinicalTrials.gov registry entry for NCT00215332 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 160-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (129% higher). The listed sponsor is DePuy Spine, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which CHARITE is the first listed.

NCT00215332 reports 10 study locations spanning 9 distinct geographic areas - top geographies include New York, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00215332 about?

NCT00215332 is a clinical study titled "CHARITE™ vs. ALIF 5-Year Follow-up". To assess the clinical and radiographic outcomes through 5-years following treatment with CHARITÉ™ Artificial Disc vs. the BAK Cage for treatment of degenerative disc disease at one level (L4-S1).

What is the current status of trial NCT00215332?

This trial is currently completed. The enrollment target is 367 participants. The study started on 2005-03. Estimated completion is 2007-07.

What conditions does trial NCT00215332 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT00215332?

The interventions under investigation include: CHARITE (DEVICE).

Who is sponsoring clinical trial NCT00215332?

This trial is sponsored by DePuy Spine, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00215332 being conducted?

This trial has 10 study locations across California, Colorado, Illinois, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.